|
|
Exchange: |
Over The Counter |
Security
Type: |
Common |
Shares
Out: |
570,750,000 |
Market
Cap: |
90.42(M) |
Last
Volume: |
695,518 |
Avg
Vol: |
3,101,442 |
52
Week Range: |
$0.1165 - $0.3 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Drugs |
Level
III Sector: |
Drug Manufacturers - Other |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile CytoDyn is a clinical-stage biotechnology company focused on the clinical development of treatments for multiple therapeutic indications based on its product candidate, leronlimab, a humanized monoclonal antibody targeting the C-C chemokine receptor type 5 receptor. Leronlimab is being investigated as a viral entry inhibitor for Human Immunodeficiency Virus. Leronlimab is also being studied in oncology, as well as other therapeutic indications, including coronavirus disease.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
0 |
0 |
0 |
0 |
Total Sell Value |
$0 |
$0 |
$0 |
$0 |
Total People Sold |
0 |
0 |
0 |
0 |
Total Sell Transactions |
0 |
0 |
0 |
0 |
End Date |
2024-06-27 |
2024-03-26 |
2023-09-26 |
2022-09-26 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Mulholland Michael D |
CFO, Treasurer and Secretary |
|
2013-10-11 |
4 |
A |
$0.00 |
$0 |
D/D |
32,407 |
32,407 |
|
- |
|
Caracciolo Anthony |
Director |
|
2013-05-31 |
4 |
A |
$0.00 |
$0 |
D/D |
3,125 |
62,136 |
|
- |
|
Nobel Michael |
Director |
|
2013-05-31 |
4 |
A |
$0.00 |
$0 |
D/D |
3,125 |
5,625 |
|
- |
|
Gould Gregory A |
Director |
|
2013-05-31 |
4 |
A |
$0.00 |
$0 |
D/D |
3,125 |
19,176 |
|
- |
|
Naydenov Jordan G |
Director |
|
2013-05-31 |
4 |
A |
$0.00 |
$0 |
D/D |
3,125 |
1,280,576 |
|
- |
|
Caracciolo Anthony |
Director |
|
2013-02-28 |
4 |
A |
$0.00 |
$0 |
D/D |
2,500 |
59,011 |
|
- |
|
Naydenov Jordan G |
Director |
|
2013-02-28 |
4 |
A |
$0.00 |
$0 |
D/D |
2,500 |
1,277,451 |
|
- |
|
Gould Gregory A |
Director |
|
2013-02-28 |
4 |
A |
$0.00 |
$0 |
D/D |
2,500 |
16,051 |
|
- |
|
Nobel Michael |
Director |
|
2013-02-28 |
4 |
A |
$0.00 |
$0 |
D/D |
2,500 |
2,500 |
|
- |
|
Green Allan M |
Director |
|
2013-02-28 |
4 |
A |
$0.00 |
$0 |
D/D |
2,500 |
2,500 |
|
- |
|
Naydenov Jordan G |
Director |
|
2012-11-30 |
4 |
A |
$0.00 |
$0 |
D/D |
1,562 |
1,274,951 |
|
- |
|
Tropp Ronald J |
Director |
|
2012-11-30 |
4 |
A |
$0.00 |
$0 |
D/D |
1,562 |
8,551 |
|
- |
|
Gould Gregory A |
Director |
|
2012-11-30 |
4 |
A |
$0.00 |
$0 |
D/D |
1,562 |
13,551 |
|
- |
|
Caracciolo Anthony |
Director |
|
2012-11-30 |
4 |
A |
$0.00 |
$0 |
D/D |
1,562 |
56,511 |
|
- |
|
Dembow George F |
Director |
|
2012-11-30 |
4 |
A |
$0.00 |
$0 |
D/D |
1,562 |
250,767 |
|
- |
|
Dembow George F |
Director |
|
2012-09-20 |
4 |
S |
$0.78 |
$50,700 |
D/D |
(65,000) |
249,205 |
|
- |
|
Dembow George F |
Director |
|
2012-09-19 |
4 |
S |
$0.83 |
$8,300 |
D/D |
(10,000) |
314,205 |
|
- |
|
Pourhassan Nader |
Interim President & CE0Officer |
|
2012-09-10 |
3/A |
IO |
$0.00 |
$0 |
I/I |
0 |
560,750 |
|
- |
|
Pourhassan Nader |
Interim President & CE0Officer |
|
2012-09-10 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
560,000 |
|
- |
|
Pourhassan Nader |
Interim President & CE0Officer |
|
2012-09-10 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
30,000 |
|
- |
|
Tropp Ronald J |
Director |
|
2012-08-31 |
4 |
A |
$0.00 |
$0 |
D/D |
3,246 |
6,989 |
|
- |
|
Gould Gregory A |
Director |
|
2012-08-31 |
4 |
A |
$0.00 |
$0 |
D/D |
3,246 |
11,989 |
|
- |
|
Dembow George F |
Director |
|
2012-08-31 |
4 |
A |
$0.00 |
$0 |
D/D |
3,246 |
324,205 |
|
- |
|
Naydenov Jordan G |
Director |
|
2012-08-31 |
4 |
A |
$0.00 |
$0 |
D/D |
3,246 |
1,273,389 |
|
- |
|
Caracciolo Anthony |
Director |
|
2012-08-31 |
4 |
A |
$0.00 |
$0 |
D/D |
3,246 |
54,949 |
|
- |
|
381 Records found
|
|
Page 8 of 16 |
|
|